AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) withdraw EU marketing application for lung cancer therapy Dato-DXd. Read more ...

AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its ...

European markets were trading higher on Tuesday, in a shortened trading session for Christmas Eve. The pan-European Stoxx 600 ...

European stocks edged higher in cautious trade on Tuesday ahead of Christmas break. The German DAX is not trading today while the ...

Catch up on all the latest pharma industry news from the past month, from breakthroughs in gene therapy to promising drug ...

AstraZeneca said it and Daiichi Sankyo decided to voluntarily withdraw the marketing authorization application in the European Union for advanced lung-cancer treatment Dato-DXd. This decision followed ...

Cytokinetics (CYTK) announced that the European Medicines Agency, EMA, has validated the Marketing Authorization Application, MAA, for ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

Anavex (AVXL) stock rallied 30% Monday after the company announced EU regulators had accepted the market application for its ...